Concepedia

Publication | Open Access

Immune competence after alemtuzumab treatment of multiple sclerosis

DOIFull Paper Access

130

Citations

7

References

2013

Year

Claire McCarthy, Orla Tuohy, D. A. S. Compston, Dinakantha Kumararatne, Alasdair Coles, Joanne Jones
Neurology

Abstract

This pilot study provides Class III evidence that patients with relapsing-remitting multiple sclerosis appear immunocompetent after treatment with alemtuzumab.

References

YearCitations

Page 1